Articles tagged with Clinical Trials
A study published in the journal Microbiome shows that fecal microbial transplants can improve gastrointestinal symptoms associated with autism spectrum disorders by 80%, while also improving social skills and sleep habits by 20-25%. The treatment, which involves transferring live gut bacteria from a healthy donor to a recipient, has s...
A clinical trial found that Verapamil therapy improved symptoms in patients with CRS and nasal polyps, representing a promising novel therapy for the disease. The treatment's effectiveness was limited among patients with higher body mass indices.
A new study published in the Society for Maternal-Fetal Medicine's annual meeting found that a weight loss intervention did not improve pregnancy outcomes despite reducing maternal weight gain. The study, MOMFIT, tested an intensive lifestyle behavioral intervention to help overweight and obese women limit gestational weight gain.
A new trivalent vaccine induces antibodies against three different parts of the virus, including two components that help HSV2 evade immune attack. The vaccine provides strong immune response and potent neutralization of four isolates of HSV2 from sub-Saharan Africa.
A randomized clinical trial found that delayed umbilical cord clamping reduced anemia prevalence in infants at 8 and 12 months of age. The intervention, which involved waiting three or more minutes after birth, increased iron stores and improved hemoglobin levels.
The two organizations will collaborate on activities in strategic mutual interest, supporting intellectual exchange of expert consulting. Researchers at Baim Institute contributed to the landmark IMMEDIATE Trial, which significantly reduced composite endpoint of cardiac arrest or mortality.
A recent randomized trial compared active monitoring, surgery, and radiation therapy for localized prostate cancer. The study's results may be limited by differences in the active monitoring protocol and advances in treatment methods.
A $1.5m grant has been awarded by Edwards Lifesciences to investigate the impact of cardiac output-guided fluid therapy on patients undergoing major gut surgery, with 2,502 patients expected to participate in the trial.
A new study from the University of Eastern Finland found that vitamin D deficiency may increase the risk of chronic headache. Men with lower serum vitamin D levels reported more frequent headaches.
A review of dermatology clinical trials found that racial and ethnic groups are underrepresented among study participants, with most being white. The lack of diversity is attributed to inadequate reporting of ethnicity and race, which may lead to a more homogenous population. To address this issue, the review suggests prioritizing raci...
An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, showing no cases among those vaccinated within 10 days. The vaccine's efficacy also led to indirect protection through herd immunity in unvaccinated people, providing weight to early trial results.
A landmark trial found that shortened antibiotic courses for ear infections in young children (9-23 months) resulted in more treatment failures and adverse events without reducing antibiotic resistance. The study showed a significantly higher risk of recurrent infections when residual fluid was present after treatment.
A study published in mBio found that fecal microbiota transplantation was effective in treating recurrent C. difficile infection, with cure rates over 90%. The researchers identified specific microorganisms, such as Clostridium Xia clade and Holdemania, which are key for a successful transplant.
Researchers found that vitamin E and selenium supplements did not prevent colorectal adenomas in a large-scale study. The findings suggest that these antioxidants have no evidence of preventing cancer.
The bionic pancreas system successfully reduced average blood glucose levels and decreased the risk of hypoglycemia in patients with type 1 diabetes living at home. The system's automated monitoring and dose delivery significantly improved blood sugar control, reducing the risk of severe hypoglycemia and nocturnal episodes.
Researchers at UCR developed therapeutic monoclonal antibodies that selectively block the action of faulty matrix metalloproteinases (MMPs), targeting cancer cell spread. Inspired by camelid antibodies, these human antibodies have convex binding sites ideal for interactions with concave MMP sites.
A stem cell-based treatment, known as the Cell Bandage, has been trialled in humans and shown to repair damaged meniscus tissue, restoring full knee function. The trial received positive results, with three out of five patients retaining an intact meniscus after 24 months.
A University of Central Florida researcher has developed a nanoparticle technology that increases natural killer cells 10,000-fold, paving the way for accelerated clinical trials. The therapy shows promise in treating acute myeloid leukemia and could lead to the creation of on-site cancer treatments.
Recent developments in dendritic cell vaccines and oncolytic immunotherapy have led to improved outcomes in melanoma patients. Various vaccine candidates are being developed and tested in clinical trials, offering new avenues for treating this malignancy.
The NCI grant supports the Methods in Clinical Cancer Research Workshop, a one-week boot camp for new oncologists taught by Dr. Daniel Von Hoff and leading experts. The program helps train clinical researchers to improve cancer clinical trial design, increasing the number of effective interventions available to patients worldwide.
A comprehensive review of homeopathy in livestock found that many clinical trials have methodological limitations, making it difficult to draw conclusions about its effectiveness. The review suggests that more research is needed to fully understand the potential benefits and risks of using homeopathy in food-producing animals.
A group of 12 high-risk acute myeloid leukemia patients who received genetically engineered immune cells are still in remission after over two years. The treatment was successful in recognizing and destroying cancer cells, with no relapse observed in this cohort.
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) who were initially ineligible for clinical trials due to existing medical conditions responded well to treatment with azacitidine (AZA) and vorinostat. Sixty-day survival rates were 83% and 79% respectively, with low-grade gastrointestinal side effects reported.
Researchers from Penn Medicine present early results from studies of CAR T cell therapy for multiple myeloma and relapsed/refractory acute lymphoblastic leukemia, showing high efficacy and safety profiles. The findings build on the team's work in CAR T cell therapies dating back to 2010.
A small study found that augmented reality and serious gaming therapy significantly reduced phantom limb pain, improving quality of life. The therapy involved training a virtual arm, racing, and copying movements, leading to halved pain intensity and frequency.
The JHU/Tufts MC/TUSM TIC will provide world-leading expertise in state-of-the-art trial design and execution of multi-site studies, particularly in neurology and cardiology. The center will lead innovative projects in clinical trial performance metrics and adaptive and integrated trial design to maximize trial performance.
The Hastings Center Report examines the ethics of crowdfunding for medical care, citing concerns over fraud, misinformation, and health inequities. The article proposes reducing the number of clinical trials to improve their quality and provide evidence-based decision-making.
A randomized clinical trial found that web-based cognitive behavior therapy for insomnia (CBT-I) improved sleep outcomes in adults. The fully automated and interactive SHUTi intervention was more effective than access to a patient education website alone, with participants showing significant improvements in sleep duration and quality.
Researchers at VIB and Ghent University have developed a diagnostic tool for Familial Mediterranean Fever, which can accurately diagnose the disease and prevent kidney failure. The tool detects changes in the body's immune reaction to pyrin, a protein mutated in FMF, and has been validated in 13 patients.
A randomized clinical trial led by Duke University School of Medicine researcher found that individual cognitive therapy relieved PTSD symptoms better and quicker than group therapy. Nearly half of participants who received one-on-one therapy improved so much they no longer carried a PTSD diagnosis, whereas almost 40 percent of those i...
A systematic review and meta-analysis found that palliative care was associated with improvements in patient quality of life, symptom burden, and advance care planning. The findings suggest that palliative care can have a positive impact on patients' lives, but more research is needed to identify the most effective interventions.
A new study found that palliative care significantly improves patients' quality of life and symptom burden, while also increasing patient and caregiver satisfaction. Researchers analyzed 43 trials involving 12,731 adults with serious illness and their family caregivers.
Residents selectively extend work shifts to facilitate care transitions, stabilize critically ill patients, and perform routine responsibilities. However, senior residents reported more frequent duty hour violations, with junior residents having the highest rate of frequent violations.
Recent studies have yielded promising results for patients with type 2 diabetes, including a 21% reduced risk of kidney dysfunction or death. Remote ischemic preconditioning has also shown sustained improvement in kidney function after transplantation. Meanwhile, trials examining dialysate sodium levels and voclosporin treatment have o...
The updated guideline suggests that more breast cancer patients can benefit from accelerated partial breast irradiation (APBI), including younger patients and those with low-risk ductal carcinoma in situ (DCIS). The guideline provides direction for the use of intraoperative radiation therapy (IORT) for early-stage breast cancer patients.
Phage therapy, which uses viruses to kill bacteria, has shown no adverse effects in clinical trials and holds promise for treating antibiotic-resistant infections. Researchers plan to use phages against E. coli in the gut or MRSA on the skin, with a goal of establishing a central repository for phages.
Researchers at University of California San Diego School of Medicine found that ustekinumab induces response and remission in patients with Crohn's disease. The study showed high remission rates among patients treated with intravenous or subcutaneous ustekinumab.
Senior officials from the FDA and NIA joined advocates and researchers to discuss collaborations for advancing Alzheimer's disease knowledge into clinical trials. The meeting aimed to identify reliable biomarkers and symptomatic approaches to improve treatment of major behavioral and psychiatric aspects of the disease.
A team of researchers has developed a new prediction model that uses crowdsourced data from 550 international researchers to provide more accurate prognosis for patients with metastatic castration-resistant prostate cancer. The model, called ePCR, was developed through a collaboration between 16 institutions and used a computational le...
Researchers found that young adults with ADHD produced more force during continuous motor tasks and had difficulty inhibiting motor responses compared to those without ADHD. This study suggests that inhibitory motor control problems may be a unique identifier for adults with ADHD.
A national survey of US general surgery residents found that 86% preferred flexible duty hour policies over standard schedules, with a stronger preference among senior residents. The study also showed that flexible hours improved patient safety and continuity of care, and reduced resident dissatisfaction.
The RE-DUAL PCI study evaluates the safety and efficacy of dabigatran etexilate in AF patients undergoing PCI. This first-ever study to use a dual versus triple antithrombotic regimen with NOAC dosages already approved for stroke prevention will inform optimal anticoagulant choices for AF patients requiring PCI.
A new wearable medical device has been found to reduce visceral fat and improve blood glucose levels in patients with type 2 diabetes. The device, which uses mild electrical stimulation and heat shock, has shown significant improvements in glycated hemoglobin values and insulin resistance.
A clinical trial is testing a new device that could ease heart failure symptoms in patients with preserved ejection fraction. The Corvia Medical InterAtrial Shunt Device makes a small hole to redistribute blood and reduce pressure, allowing patients like Jimmy McMillan to breathe better and live more comfortably.
Researchers are testing stem cell therapy to reprogram heart cells in patients with HFpEF, a condition causing severe disability and high mortality. The trial aims to improve treatment options for this growing epidemic, which disproportionately affects women and African-Americans.
A new study by Mark J. Bolland and his team analyzed 33 randomized controlled trials, finding reported results that differed markedly from what could be expected statistically. The trials reported large reductions in hip fractures, but the findings are not consistent with results found in similar studies by other researchers.
The Walter Reed Army Institute of Research has begun a Phase 1 human clinical trial to test the safety and immunogenicity of the ZPIV vaccine, developed using an inactivated flavivirus vaccine platform. The trial involves 75 healthy adults and is part of the US Department of Defense response to the ongoing Zika virus outbreak.
The first of five clinical trials for an investigational Zika vaccine began at the Walter Reed Army Institute of Research, testing the safety and ability of the ZPIV vaccine to generate an immune system response. The Phase 1 trial aims to enroll 75 people aged 18-49 with no prior flavivirus infection.
A recent study published in the journal Stem Cells found that autologous stem cell therapy after traumatic brain injury appears to reduce inflammation and preserve critical brain regions. Researchers used this approach on 25 patients, including those with severe TBI, showing promising results.
The RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in preventing recurrent ischemic stroke. Key findings showed a 45% relative risk reduction in recurrent ischemic stroke for the PFO group.
A phase-1 clinical trial demonstrates that gene therapy can restore functional type-7 collagen protein expression and improve wound healing in patients with recessive dystrophic epidermolysis bullosa. The treatment appears safe and well-tolerated, with improved outcomes for patients who had not healed for five years.
The SENTINEL trial found that the Sentinel device was safe during TAVR but did not meet its primary efficacy endpoint of reducing median new lesion volume on MRI. Despite this, embolic protection resulted in a reduction of new lesion volume after adjusting for confounders.
The PLATINUM DIVERSITY trial found that women and minorities had higher rates of death and myocardial infarction after coronary stent procedures compared to white men. The study also highlighted the need for further research into the causes of these observed gradients of risk.
The Nordic-Baltic-British Left Main Revascularization Study (NOBLE) found that CABG reduced the five-year risk of MACCE compared to PCI for LMCA disease. The study demonstrated superiority of CABG over PCI in reducing non-procedural myocardial infarction and stroke.
The ILUMIEN III trial found that optical coherence tomography-guided PCI resulted in similar minimal stent area compared to IVUS-guidance, while also showing improved stent expansion and acute procedural success compared to angiography-guidance. Untreated major dissections were more common after IVUS-guided PCI than OCT-guided PCI.
A study found that nearly half of cancer patients expect their tumors to shrink after participating in phase I clinical trials, despite the realistic response rate being much lower. The results highlight the need to improve patient information and consent forms.
A new study from Johns Hopkins Medicine found that while training doesn't change neurological repair in chronic stroke patients, it can help them learn new motor skills and achieve more independence. The researchers used a video game-like test to assess the patients' ability to perform tasks.
A case report reveals that high-dose lutein supplements can cause the formation of crystal deposits in the eyes, highlighting the importance of balanced intake. The study suggests that patients should follow a diet rich in eye-healthy foods and only take AREDS2 supplements as recommended by their ophthalmologist.
Researchers found that unconscious increases in arousal affect participants' confidence in their visual decisions. This effect is counteracted by artificially increased arousal, suggesting a complex relationship between conscious introspection and physiological states.
The ECOG-ACRIN Cancer Research Group is recruiting medical facilities for the Tomosynthesis Mammography Imaging Screening Trial (TMIST), a large-scale breast cancer screening trial comparing digital breast tomosynthesis with standard digital mammography. The study aims to provide a modern basis for continued use of mammography.